Cumin Cuminum cyminum L.
Also called: cummin
Cumin is the seed of Cuminum cyminum, an annual plant native from Iraq to Afghanistan and used widely as a spice. Its volatile oil contains cuminaldehyde. Supplement trials have mostly examined blood sugar, lipids and other metabolic measures.
- Category
- Botanical
- Part used
- Seed (also seed oil and extracts)
- Strongest evidence
- B Some positive trials
- Native range
- Native from Iraq to Afghanistan (POWO: "Iraq to Afghanistan")
- Reviewed
- 2026-10-29
Class 1 Well studied in people. A 2025 meta-analysis (Front Nutr) included 9 placebo-controlled RCTs (531 adults with metabolic disorders, all in Iran), all of oral cumin essential oil per its table; 2 of the 9 actually tested caraway or black caraway, leaving 7 of cumin alone. [5]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BBlood sugar and weight3 topics
CPregnancy and infants1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood sugar measures in adults | C | A 2021 meta-analysis of 8 RCTs (552 adults) found no significant effect of cumin on fasting glucose, insulin or HOMA-IR versus placebo. [3] |
| Blood sugar in chronic disease | C | A second 2021 meta-analysis of 8 controlled trials in people with chronic diseases reported lower fasting glucose and HbA1c, but no significant change in insulin. [4] |
| Metabolic syndrome components | B | A 2025 meta-analysis of 9 RCTs of oral essential oil (8–24 weeks; 2 trials tested caraway or black caraway) in adults with metabolic disorders found lower fasting glucose, triglycerides and waist size and higher HDL; heterogeneity was high. [5] |
| Breast-milk supply | C | LactMed: cumin has been used as a galactogogue with some literature support, including in herbal mixtures; no data exist on its safety in nursing mothers or infants. [1] |
Main constituents: Volatile oil containing cuminaldehyde and other aldehydes; flavonoids and terpenes in the seed [1]; Cuminaldehyde described as the major bioactive [2]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingLactMed: no data exist on the excretion of cumin components into breast milk or on the safety and efficacy of cumin in nursing mothers or infants.
1 statement in the profile.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications1 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Cumin is generally well tolerated, but occasional phototoxic skin reactions have been reported after contact with the oil; people allergic to cumin or related herbs should avoid it (LactMed). [1]
- No data exist on the excretion of cumin components into breast milk or on safety in nursing mothers or infants (LactMed). [1]
Regulatory status
- US: FDA's published NDI notification list has 1 entry naming cumin (Cuminum cyminum) (earliest NDI 128 submitted 2001-11-09; most recent NDI 128 submitted 2001-11-09). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. The entry is a multi-ingredient product in which Cuminum cyminum is one of several components. [6]
- US food use: 21 CFR 182.10 lists cumin (Cuminum cyminum L.) among spices and natural seasonings generally recognized as safe for their intended use. [7]
- US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed, and that it generally does not approve supplement claims or other labeling before use. [8]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 1 entry naming cumin (Cuminum cyminum) (earliest NDI 128 submitted 2001-11-09; most recent NDI 128 submitted 2001-11-09). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. The entry is a multi-ingredient product in which Cuminum cyminum is one of several components. [P2]
- Food use: 21 CFR 182.10 (spices and other natural seasonings and flavorings) lists cumin (Cuminum cyminum L.) as generally recognized as safe for its intended use. [P3]
- Food use: 21 CFR 182.20 (essential oils, oleoresins and natural extractives) lists cumin (Cuminum cyminum L.) as generally recognized as safe for its intended use. [P4]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test of each dietary-ingredient lot (at least one appropriate test or examination) — Required for any component that is a dietary ingredient under 21 CFR 111.75(a)(1)(i), unless FDA grants a petition exemption. [P7]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- LactMed: no data exist on the excretion of cumin components into breast milk or on the safety and efficacy of cumin in nursing mothers or infants. [P1]
Sources for this profile
- Drugs and Lactation Database (LactMed). Cumin. National Institute of Child Health and Human Development (revised 2026-10-15; NBK501873; PMID 30000933), 2026-10-15. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 182.10 Spices and other natural seasonings and flavorings (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
- eCFR. 21 CFR 182.20 Essential oils, oleoresins (solvent-free), and natural extractives (including distillates) (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
- IARC Monographs. Agents Classified by the IARC Monographs, Volumes 1–142 (list last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (list of 2-year studies; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
Sources
- Drugs and Lactation Database (LactMed). Cumin. National Institute of Child Health and Human Development (revised 2026-10-15; NBK501873; PMID 30000933), 2026-10-15. pubmed.ncbi.nlm.nih.gov
- Singh N, et al. A review on traditional uses, phytochemistry, pharmacology, and clinical research of dietary spice Cuminum cyminum L. Phytother Res 2021;35(9):5007-5030 (PMID 33893678), 2021-09. pubmed.ncbi.nlm.nih.gov
- Karimian J, et al. The effect of cumin (Cuminum cyminum L.) supplementation on glycemic indices: a systematic review and meta-analysis of randomized controlled trials. Phytother Res 2021;35(8):4127-4135 (PMID 33720457), 2021-08. pubmed.ncbi.nlm.nih.gov
- Tavakoli-Rouzbehani OM, et al. The effects of Cuminum cyminum on glycemic parameters: a systematic review and meta-analysis of controlled clinical trials. J Ethnopharmacol 2021;281:114510 (PMID 34371114), 2021-12-05. pubmed.ncbi.nlm.nih.gov
- Liu M, et al. Potential benefits of Cuminum cyminum L supplementation on components of metabolic syndrome in adults with metabolic disorders: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Front Nutr 2025;12:1618108 (PMID 41608519), 2026-01-13. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 182.10 Spices and other natural seasonings and flavorings (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Cuminum cyminum L. (accessed 2026-10-29). powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.